ECCMID 2023
Remdesivir Reduces Readmission Risk by 16% Among Immunocompromised Patients With COVID-19
Remdesivir (Veklury, Gilead) may reduce risk for hospital readmission by as much as 16% among immunocompromised ...
APRIL 21, 2023
2 Steps Are Better Than 1 for CDI Testing
A two-step algorithm for CDI testing may reduce unnecessary treatment and improve detection.
APRIL 18, 2023
Antibiotics Do Not Lower Risk for Death in Adults Hospitalized for Viral RTIs
Antibiotic therapy was initiated in 55% of patients with viral RTIs at admission to hospital.
APRIL 18, 2023
MDR Bacteria Found in 40% of Spanish Supermarket Meat Samples
Forty percent of meat samples tested from supermarkets in Spain were positive for multidrug-resistant (MDR) ...
APRIL 18, 2023
Obese and Female Patients More Likely to Have Long COVID
Obesity and female sex are consistent determinants for symptoms persisting after COVID-19, according to data shared ...
APRIL 18, 2023
Comorbidities and Insurance Coverage Influence Risk for IPD, Pneumonia and OM in Children
Very young children with comorbidities as well as those who are on Medicaid see more pneumococcal disease than ...
APRIL 17, 2023
